Liver transplantation is an effective treatment for end-stage liver disease. Cardiovascular complications are the common causes of death in liver transplant recipients. The presence of cirrhosis cardiomyopathy has a potential impact on the prognosis of liver transplant recipients. Therefore, it is important to identify the high risk factors with cirrhotic cardiomyopathy before transplantation, so as to intervene earlier and improve the prognosis of patients.
Study Type
OBSERVATIONAL
Enrollment
850
perioperative cardiovascular events
there are differences between 2 groups.
Time frame: 2012.1.1-2022.8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.